$CRVS

Corvus Pharmaceuticals, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA

Charts by TradingView

CRVS chart

What traders are saying about $CRVS

Latest posts

Corvus Pharmaceuticals, Inc. news

Corvus Pharmaceuticals, Inc. key financials

USD2025202420232022
Net income-$15.3M-$62.3M-$27.0M-$41.3M
Diluted EPS$-0.53$-1.02$-0.56$-0.89
Total assets (year end)$71.1M$68.9M$45.6M$68.2M
Cash and equivalents (year end)$4.6M$8.7M$12.6M$13.2M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Corvus Pharmaceuticals, Inc.

Ticker
CRVS (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
South San Francisco, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1626971

Frequently asked questions

What exchange is Corvus Pharmaceuticals, Inc. listed on?

Corvus Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol CRVS.

What industry is Corvus Pharmaceuticals, Inc. in?

Corvus Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Corvus Pharmaceuticals, Inc. headquartered?

Corvus Pharmaceuticals, Inc.'s business address on file with the SEC is in South San Francisco, CA.

When does Corvus Pharmaceuticals, Inc.'s fiscal year end?

Corvus Pharmaceuticals, Inc.'s fiscal year ends on December 31.